Drug Type Small molecule drug |
Synonyms Flunisolide (JAN/USP), Flunisolide anhydrous, Flunisolide hemihydrate + [13] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (24 Sep 1981), |
Regulation- |
Molecular FormulaC24H31FO6 |
InChIKeyXSFJVAJPIHIPKU-XWCQMRHXSA-N |
CAS Registry3385-03-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00324 | Flunisolide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | United States | 17 Aug 1984 | |
Rhinitis, Allergic, Perennial | United States | 24 Sep 1981 | |
Rhinitis, Allergic, Seasonal | United States | 24 Sep 1981 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
airway disease | Clinical | United States | 01 Mar 2015 | |
Childhood asthma | Clinical | United States | 01 Mar 2015 |
Not Applicable | 26 | (Flunisolide 160 mcg Per Day) | ffymfhxvub(hbbpawdzda) = caopvjpxme xqahjtrxub (mwdylgpftf, iiycksqbps - fcabltugxv) View more | - | 20 Oct 2017 | ||
(Flunisolide 320 mcg Per Day) | ffymfhxvub(hbbpawdzda) = bffyokkbvy xqahjtrxub (mwdylgpftf, ilkjidhcso - bbzphsecqk) View more |